1. FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment Trial. Issue 3 (March 2019) Authors: Nti, Akosua A.; Serrano, Leona W.; Sandhu, Harpal S.; Uyhazi, Katherine E.; Edelstein, Ilaina D.; Zhou, Elaine J.; Bowman, Scott; Song, Delu; Gangadhar, Tara C.; Schuchter, Lynn M.; Mitnick, Sheryl; Huang, Alexander; Nichols, Charles W.; Amaravadi, Ravi K.; Kim, Benjamin J.; Aleman, Tomas S. Journal: Retina Issue: Volume 39:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗